← All sarcoma trials
Recruiting now—Ages 18 Years and up

Neurofibromatosis Type 1 Tumor Early Detection Study

Sponsor: David Miller · NCT06515860 on ClinicalTrials.gov ↗

Bring this to your care team →

Conditions studied

Neurofibromatosis Type 1Neurofibromatosis 1Plexiform NeurofibromaPlexiform NeurofibromasMalignant Peripheral Nerve Sheath TumorMalignant Peripheral Nerve Sheath TumorsAtypical Neurofibroma

What it tests

  • Liquid biopsy for MPNST developmentdiagnostic_test

Where it's running1 site

  • Boston Children's Hospital

    Boston, Massachusetts 02115

    Recruiting now
See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

* 18 years and older (adults only)
* Neurofibromatosis Type 1 (NF1) diagnosis (2021 Revised Diagnostic Criteria, PMID: 34012067)
* History of plexiform neurofibroma (PN)
* Able to read and understand English or Spanish
* Live in the USA

Exclusion Criteria:

* Are children (younger than 18 years old)
* Do not have NF1
* Have no evidence of PN
* Are not able to read and understand English or Spanish

Updated 2026-01-09 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.